DENALI THERAPEUTICS INC. Salaries - How Much Does Denali Therapeutics Inc. Pay?

Denali Therapeutics Inc. Company Overview

• WebSite: denalitherapeutics.com
• Headquarters: South San Francisco, CA

• Size: 200 - 500
• Founded: 2015

• Type:

• Revenue: $200M - $500M
• Industry: Biotechnology

• Related Companies:

• About:
  Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 and DNL151, which are in Phase 1 clinical trials for Parkinson's disease. It is also developing receptor interacting serine/threonine protein kinase 1 (RIPK1) product candidates, such as DNL747, a selective and brain-penetrant small molecule RIPK1 inhibitor product candidate that is in Phase 1b clinical trial for Alzheimer's disease and amyo ... trophic lateral sclerosis (ALS). In addition, the company develops enzyme transport vehicle: iduronate 2-sulfatase, an enzyme replacement therapy program for MPS II, a lysosomal storage disorder; antibody transport vehicle (ATV): alpha-synuclein (aSyn) program, a protein that spreads throughout the brain in Parkinson's disease; ATV: triggering receptor expressed in myeloid cells 2, a therapeutic candidate designed to rescue microglial function in Alzheimer's disease; and ATV: Tau, a therapeutic targeting the spreading of Tau. Further, it is developing LF1, an undisclosed large molecule program to treat neurodegenerative diseases. Additionally, the company has various seed programs under the research, discovery, and preclinical stages of development. Denali Therapeutics Inc. has collaboration agreement with Takeda Pharmaceutical Company and Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is based in South San Francisco, California. More

The average salary for Denali Therapeutics Inc. Security positions may fluctuate based on factors such as location, department, and job description. The following table displays job titles that might pique your interest, along with associated salary ranges and total compensation packages. Compensation for the same role at Denali Therapeutics Inc. can vary due to disparities in experience, skills, competencies, and education.

For Employers Make Pay Decisions with Confidence

Salary.com provides salary data for 15,000+ Job Titles, 27,000+ Compensable Factors, and 800 million Market Data points.

Price a Job

Loading results...

No data is available based on your input.

Associate Director, Finance	$175,080	Denali Therapeutics Inc.
Associate Director, Quality Assurance	$94,836	Denali Therapeutics Inc.
Associate Director, Toxicology	$81,894	Denali Therapeutics Inc.
Associate Scientist, Bioanalytical, DMPK	$85,174	Denali Therapeutics Inc.
Associate Scientist, DMPK	$110,318	Denali Therapeutics Inc.

Get unlimited access to Denali Therapeutics Inc. salaries by Share you Salary.

Share Your Salary Anonymously

The average salary for Denali Therapeutics Inc. employees is around $113,571 to $145,749. It's important to bear in mind that individual salary experiences can significantly differ due to factors like job roles, departments, locations, and individual skills and educational backgrounds.

DISCLAIMER: The salary range presented here is an estimation that has been derived from our proprietary algorithm. It should be noted that this range does not originate from the company's factual payroll records or survey data. Add a report this company salary at the end of Denali Therapeutics Inc. average salary.

Report this Company Salary